BioCentury
ARTICLE | Clinical News

Citalopram regulatory update

June 21, 2004 7:00 AM UTC

BVF said FDA accepted for review an NDA for citalopram, a selective serotonin reuptake inhibitor (SSRI). BVF said the NDA was filed under the provisions of section 505(b)(2) of the Food, Drug and Cosm...